14-day Premium Trial Subscription Sign Up For FreeGet Free

Biocept Stock Forecast NASDAQ:BIOC

Price Target and Analyst Ratings

Most Recent Rating

Maxim Group is very positive about BIOC and gave it a "Buy" rating on December 11, 2020. The price target was set to $20.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2020-12-11 Buy Initiated by Maxim Group $5.41 $20.00
2020-11-13 Buy Reiterated by Maxim Group $4.78
2020-08-13 Buy Target Raised by Maxim Group $1.01 $1.00 → $2.00
2020-08-04 Buy Reiterated by Maxim Group $0.78 $1.00
2020-06-23 Buy Reiterated by Maxim Group $0.69 $1.00
2020-05-14 Buy Initiated by Brookline Capital Management $0.41
2020-04-14 Buy Reiterated by Maxim Group $0.45 $1.00

BIOC Stock Trend

Given the current short-term trend, the stock is expected to fall -15.02% during the next 3 months and, with a 90% probability hold a price between $2.73 and $3.33 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-20 $3.20 $3.56 $3.91
2021-09-21 $3.19 $3.54 $3.90
2021-09-22 $3.18 $3.53 $3.89
2021-09-23 $3.17 $3.52 $3.88
2021-09-24 $3.16 $3.51 $3.86
2021-09-27 $3.15 $3.50 $3.85
2021-09-28 $3.14 $3.49 $3.84
2021-09-29 $3.13 $3.48 $3.83
2021-09-30 $3.11 $3.47 $3.82
2021-10-01 $3.10 $3.46 $3.81
2021-10-04 $3.09 $3.45 $3.80
2021-10-05 $3.08 $3.43 $3.79
2021-10-06 $3.07 $3.42 $3.78
2021-10-07 $3.06 $3.41 $3.77
2021-10-08 $3.05 $3.40 $3.75
2021-10-11 $3.04 $3.39 $3.74
2021-10-12 $3.03 $3.38 $3.73
2021-10-13 $3.02 $3.37 $3.72
2021-10-14 $3.00 $3.36 $3.71
2021-10-15 $2.99 $3.35 $3.70
2021-10-18 $2.98 $3.34 $3.69
2021-10-19 $2.97 $3.32 $3.68
2021-10-20 $2.96 $3.31 $3.67
2021-10-21 $2.95 $3.30 $3.66
2021-10-22 $2.94 $3.29 $3.64
2021-10-25 $2.93 $3.28 $3.63
2021-10-26 $2.92 $3.27 $3.62
2021-10-27 $2.91 $3.26 $3.61
2021-10-28 $2.89 $3.25 $3.60
2021-10-29 $2.88 $3.24 $3.59

About Biocept

Biocept Biocept, Inc., a cancer diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The company’s cancer assays provide an information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors. It offers assays for solid tumor indications, such as ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT